Endocyte, Inc. (Nasdaq:ECYT) reported financial results for the first quarter ended March 31, 2011, and provided an operational update. “We were pleased that in the first few months since our initial public offering, we have achieved some very significant milestones,” said Ron Ellis, Endocyte’s president and CEO. “Our recent interactions with the European Medicines Agency, including the Scientific Advice Working Party, were productive and led to our decision to seek conditional marketing authorization for both EC145 and EC20 in the EU, which could potentially accelerate our commercial timeline. As anticipated, we also began enrolling patients in our Phase 3 PROCEED trial for EC145 in women with platinum-resistant ovarian cancer. Our plan is to file for approval in the U.S. based on the PROCEED results.”
Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases.
Cleantech Transit, Inc. (CLNO)
Biomass energy can really come from so many sources. What we are talking about here is any animal or plant-derived materials, for example such as wood, woodchips, paper, trash, agricultural crops, animal waste (slaughtering), manure, sewage, hemp, and algae.
Biomass energy in the forms of gas can occur spontaneously, as marshgas, or landfill gas for example, but alcohols do not. Agricultural wastes or manures undergo certain processes first.
Bio energy is renewable and solar in origin. It is renewable as the materials it comes from can be replaced, or grown, in a short period of time.
And burning biofuels is not necessarily a contributor to global warming in the way that fossil fuels are.
Biofuels do not add to the net amount of CO2 already present in the atmosphere. This is because carbon in the biofuel is locked up only for the short period of time in plants or animals and can be considered as recycled as newly growing crops and animals once again take up the atmospheric CO2 used in burning.
Cleantech Transit, Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects.
Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company’s manufacturing clients worldwide.
Cleantech Transit, Inc. original aim was to develop opportunities utilizing advances in technology and manufacturing processes in order to develop significant market share in the growing clean energy public transportation sector.
With the growth in the green sector as a whole the CLNO has expanded its focus to invest directly in specific projects. Recent advances in the technology of converting wood waste into power have so greatly enhanced the economic value of their systems they have launched the biomass division as a separate company, Phoenix Energy, to focus exclusively on generating greater returns for manufacturing clients worldwide.
For more information about Cleantech Transit, Inc. http://www.cleantechtransitinc.com
National Health Partners, Inc. (NHPR)
Medical expenses are rising faster than the costs of any other service. They are climbing at rates that exceed not only those of inflation and dollar depreciation but even the Federal government itself. In fact, they are consuming an ever larger share of personal and national incomes.
Some 40 years ago American medical spending was estimated at 5 percent of national income; today it is calculated at some 16.5 percent and rising continually. Several reform proposals in Congress would boost the share ever higher.
Many observers offer lucid explanations of the medical-spending explosion. Some are convinced that the present generation of Americans, which enjoys a level of income and living standard higher than that of its forebears, is more mindful of health and wholesome living and, therefore, is spending a larger share of income on health care.
National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna.
The company’s primary target customer group is the 47 million Americans who have no health insurance of any kind. The company’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage. The company is headquartered in Horsham, Pennsylvania.
National Health Partners, Inc. recently announced that it has signed a new agreement with a major marketing company that will significantly enhance the growth of its CARExpress membership base.
According to the Company, this deal, in combination with the previous partnership with Xpress Healthcare, will enable the company to build its membership base exponentially, initially generating in excess of an additional 2,000 new members per month. The new campaign is set to launch within the next few weeks and will provide a material positive impact on the company’s 2nd quarter sales.
National Health Partners anticipate that this new marketing agreement will provide a major impact on their overall sales not only for the 2nd quarter, but more importantly for the year. They look forward to building on the profits that they anticipate generating in 2011 that will be driven by substantial growth in sales of their CARExpress health discount programs. The combination of their substantial growth with their low price-to-equity ratio should reflect itself in the price of their stock over the coming months.
For more information about National Health Partners, Inc visit its website www.nationalhealthpartners.com
New England Bancshares, Inc. (Nasdaq:NEBS) announced that the Company’s Board of Directors declared a cash dividend for the quarter ended March 31, 2011 of $0.03 per share. The cash dividend will be payable on June 10, 2011 to stockholders of record on May 24, 2011. New England Bancshares, Inc. is headquartered in Enfield, Connecticut, and operates New England Bank with fifteen banking centers servicing the communities of Bristol, Cheshire, East Windsor, Ellington, Enfield, Manchester, Plymouth, Southington, Suffield, Wallingford and Windsor Locks. For more information regarding New England Bank’s products and services, please visit www.nebankct.com.
New England Bancshares, Inc. operates as the holding company for New England Bank that provides various commercial banking products and services.
Cyberonics, Inc. (NASDAQ:CYBX) announced that the company will report financial results for the fourth quarter and fiscal year ended April 29, 2011, on Thursday, June 2, 2011, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). The conference call will be available to interested parties through a live audio webcast in the investor relations section of Cyberonics’ corporate website at http://www.cyberonics.com.
Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, sale, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of refractory epilepsy and treatment-resistant depression.